Glaxo Files Its Entry in Race for a Malaria Vaccine

An experimental malaria vaccine GlaxoSmithKline filed with regulators Thursday could help fight one of the world's biggest killers—but a rival compound partly developed in a Maryland kitchen could prove even more effective.



from WSJ.com: US Business http://ift.tt/WKWhsR

via IFTTT